<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">rpcardio</journal-id><journal-title-group><journal-title xml:lang="en">Rational Pharmacotherapy in Cardiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Рациональная Фармакотерапия в Кардиологии</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1819-6446</issn><issn pub-type="epub">2225-3653</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20996/1819-6446-2024-3113</article-id><article-id custom-type="edn" pub-id-type="custom">ULNDYU</article-id><article-id custom-type="elpub" pub-id-type="custom">rpcardio-3113</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>POINT OF VIEW</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ТОЧКА ЗРЕНИЯ</subject></subj-group></article-categories><title-group><article-title>The main misconceptions in cardiology concerning obesity</article-title><trans-title-group xml:lang="ru"><trans-title>Основные стереотипные убеждения в кардиологической практике относительно ожирения</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0143-0849</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Елиашевич</surname><given-names>С. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Eliashevich</surname><given-names>S. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Елиашевич Софья Олеговна, руководитель лаборатории изучения и коррекции пищевого поведения</p><p>Москва </p></bio><bio xml:lang="en"><p> Sofia O. Eliashevich </p><p> Moscow </p></bio><email xlink:type="simple">elsofol@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0607-5551</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Игнатиади</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Ignatiadi</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Игнатиади Анастасия Сергеевна</p><p>Москва </p></bio><bio xml:lang="en"><p> Anastasia S. Ignatiadi </p><p> Moscow </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5816-3476</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мишарова</surname><given-names>А. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Misharova</surname><given-names>A. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мишарова Алина Павловна</p><p>Москва </p></bio><bio xml:lang="en"><p> Alina P. Misharova </p><p> Moscow </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4453-8430</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Драпкина</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Drapkina</surname><given-names>O. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Драпкина Оксана Михайловна</p><p>Москва </p></bio><bio xml:lang="en"><p> Oxana M. Drapkina </p><p> Moscow </p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр терапии и профилактической медицины Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>02</day><month>12</month><year>2024</year></pub-date><volume>20</volume><issue>5</issue><fpage>574</fpage><lpage>580</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Eliashevich S.O., Ignatiadi A.S., Misharova A.P., Drapkina O.M., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Елиашевич С.О., Игнатиади А.С., Мишарова А.П., Драпкина О.М.</copyright-holder><copyright-holder xml:lang="en">Eliashevich S.O., Ignatiadi A.S., Misharova A.P., Drapkina O.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rpcardio.online/jour/article/view/3113">https://www.rpcardio.online/jour/article/view/3113</self-uri><abstract><p>This article reviews common myths and stereotypes about obesity that distort the understanding of its causes and pathogenesis and contribute to the disease stigmatization among the cardiology medical community. Obesity is a chronic, relapsing, multifactorial disease characterized by excessive formation of adipose tissue, progressing in its natural course and, as a rule, having an increased cardiometabolic risk. For effective prevention of complications, it is necessary to start treating obesity at the risk and pre-disease stages (abdominal obesity and overweight). The causes of obesity include genetic, metabolic, social and environmental factors. The review emphasizes that obesity is not exclusively a consequence of a lack of willpower in choosing food products according to the rules of healthy eating or a sedentary lifestyle. Many stereotypes, such as the idea that all patients with excess body weight have an alimentary genesis of the disease and all clinical "findings" are associated with obesity, do not correspond to reality and hinder effective prevention and treatment strategies. No other chronic non-communicable disease is as stigmatized as obesity. Moreover, despite the development of modern pharmacotherapy, behavioral therapy for obesity, and bariatric surgery, there is high clinical inertia in timely initiation of treatment for this disease. Body weight is becoming the same target indicator in general therapeutic practice as blood pressure or glycemia. Modern medicine dictates the need to rely solely on the evidence base to refute myths in order to create a more inclusive and supportive environment that promotes the health and well-being of patients.</p></abstract><trans-abstract xml:lang="ru"><p>  </p><p>В данной статье рассматриваются распространенные мифы и стереотипные утверждения об ожирении, искажающие понимание причин и патогенеза и способствующие стигматизации данного заболевания среди кардиологической медицинской общественности. Ожирение является хроническим рецидивирующим многофакторным заболеванием, проявляющимся избыточным образованием жировой ткани, прогрессирующим при естественном течении и, как правило, имеющим повышенный кардиометаболический риск. Для эффективной профилактики осложнений необходимо начинать лечить ожирение на стадиях риска и предболезни (абдоминальное ожирение и избыточная масса тела). Среди причин ожирения выделяют генетические, метаболические, социальные и экологические факторы. В обзоре подчеркивается, что ожирение не является исключительно следствием недостатка силы воли в выборе пищевых продуктов согласно правилам здорового питания или малоподвижного образа жизни. Многие стереотипы, такие как представление о том, что у всех пациентов с повышенной массой тела отмечается алиментарный генез заболевания и все клинические "находки" ассоциированы с ожирением, не соответствуют действительности и препятствуют эффективным стратегиям профилактики и лечения. Ни одно их хронических неинфекционных заболеваний не подвергается такой стигматизации, как ожирение. Более того, несмотря на развитие современной фармакотерапии, поведенческой терапии ожирения и бариатрической хирургии наблюдается высокая клиническая инертность в своевременной инициации лечения этого заболевания. Масса тела становится таким же целевым показателем в общетерапевтической практике как уровень артериального давления или гликемии. Современная медицина диктует необходимость опираться исключительно на доказательную базу для опровержения мифов с целью создания более инклюзивной и поддерживающей среды, способствующей здоровью и благополучию пациентов.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ожирение</kwd><kwd>избыточная масса тела</kwd><kwd>мифы</kwd><kwd>обмен веществ</kwd><kwd>сила воли</kwd><kwd>микробиота</kwd><kwd>наследственность</kwd><kwd>стигматизация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>obesity</kwd><kwd>overweight</kwd><kwd>myths</kwd><kwd>metabolism</kwd><kwd>willpower</kwd><kwd>microbiota</kwd><kwd>heredity</kwd><kwd>stigmatization</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223-49. DOI: 10.1016/S0140-6736(20)30752-2.</mixed-citation><mixed-citation xml:lang="en">GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223-49. DOI: 10.1016/S0140-6736(20)30752-2.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Okunogbe A, Nugent R, Spencer G, et al. Economic impacts of overweight and obesity: current and future estimates for 161 countries. BMJ Glob Health. 2022;7(9):e009773. DOI: 10.1136/bmjgh-2022-009773.</mixed-citation><mixed-citation xml:lang="en">Okunogbe A, Nugent R, Spencer G, et al. Economic impacts of overweight and obesity: current and future estimates for 161 countries. BMJ Glob Health. 2022;7(9):e009773. DOI: 10.1136/bmjgh-2022-009773.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Драпкина О. М., Концевая А. В., Калинина А. М. и др. Профилактика хронических неинфекционных заболеваний в Российской Федерации. Национальное руководство 2022. Кардиоваскулярная терапия и профилактика. 2022;21(4):3235. DOI: 10.15829/1728-8800-2022-3235.</mixed-citation><mixed-citation xml:lang="en">Drapkina OM, Kontsevaya AV, Kalinina AM, et al. 2022 Prevention of chronic non-communicable diseases in the Russian Federation. National guidelines. Cardiovascular Therapy and Prevention. 2022;21(4):3235 (In Russ.) DOI: 10.15829/1728-8800-2022-3235.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Aune D, Sen A, Prasad M, et al. BMI and all-cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ. 2016;353:i2156. DOI: 10.1136/bmj.i2156.</mixed-citation><mixed-citation xml:lang="en">Aune D, Sen A, Prasad M, et al. BMI and all-cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ. 2016;353:i2156. DOI: 10.1136/bmj.i2156.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Драпкина О. М., Купрейшвили Л. В., Фомин В. В. Композиционный состав тела и его роль в развитии метаболических нарушений и сердечно-сосудистых заболеваний. Кардиоваскулярная терапия и профилактика. 2017;16(5):81-5. DOI: 10.15829/1728-8800-2017-5-81-85.</mixed-citation><mixed-citation xml:lang="en">Drapkina OM, Kupreyshvili LV, Fomin VV. Body composition and its role in development of metabolic disorders and cardiovascular diseases. Cardiovascular Therapy and Prevention. 2017;16(5):81-5 (In Russ.) DOI: 10.15829/1728-8800-2017-5-81-85.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Голоунина О. О., Фадеев В. В., Белая Ж. Е. Современные рекомендации по диагностике саркопении. Клиническая медицина. 2023;101(4-5):198-207. DOI: 10. 30629/0023-2149-2023-101-4-5-198-207.</mixed-citation><mixed-citation xml:lang="en">Golounina OO, Fadeev VV, Belaya ZhE. Modern guidelines for the diagnosis of sarcopenia. Klinicheskaya meditsina. 2023;101(4-5):198-207. (In Russ) DOI: 10. 30629/0023-2149-2023-101-4-5-198-207.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Драпкина О. М., Концевая А. В., Калинина А. М. и др. Коморбидность пациентов с хроническими неинфекционными заболеваниями в практике врачатерапевта. Евразийское руководство. Кардиоваскулярная терапия и профилактика. 2024;23(3):3996. DOI: 10.15829/1728-8800-2024-3996.</mixed-citation><mixed-citation xml:lang="en">Drapkina OM, Kontsevaya AV, Kalinina AM, et al. Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines. Cardiovascular Therapy and Prevention. 2024;23(3):3996 (In Russ) DOI: 10.15829/1728-8800-2024-3996.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Koskinas KC, Van Craenenbroeck EM, Antoniades C, et al. Obesity and cardiovascular disease: an ESC clinical consensus statement. Eur J Prev Cardiol. 2024:zwae279. DOI: 10.1093/eurjpc/zwae279.</mixed-citation><mixed-citation xml:lang="en">Koskinas KC, Van Craenenbroeck EM, Antoniades C, et al. Obesity and cardiovascular disease: an ESC clinical consensus statement. Eur J Prev Cardiol. 2024:zwae279. DOI: 10.1093/eurjpc/zwae279.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Burridge K, Christensen SM, Golden A, et al. Obesity history, physical exam, laboratory, body composition, and energy expenditure: an Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obes Pillars. 2022;1:100007. DOI: 10.1016/j.obpill.2021.100007.</mixed-citation><mixed-citation xml:lang="en">Burridge K, Christensen SM, Golden A, et al. Obesity history, physical exam, laboratory, body composition, and energy expenditure: an Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obes Pillars. 2022;1:100007. DOI: 10.1016/j.obpill.2021.100007.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Драпкина О. М., Максимова О. А., Шептулина А. Ф., Джиоева О. Н. Биоимпедансный анализ состава тела: что важно знать терапевту? Профилактическая медицина. 2022;25(10):91-6]. DOI: 10.17116/profmed20222510191.</mixed-citation><mixed-citation xml:lang="en">Drapkina OM, Maksimova OA, Sheptulina AF, Dzhioeva ON. Bioimpedance analysis of body composition: what should general practitioner know? Russian Journal of Preventive Medicine. 2022;25(10):91-6 (In Russ.) DOI: 10.17116/profmed20222510191.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Shuster A, Patlas M, Pinthus JH, Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol 2012;85(1009):1-10. DOI: 10.1259/bjr/38447238.</mixed-citation><mixed-citation xml:lang="en">Shuster A, Patlas M, Pinthus JH, Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol 2012;85(1009):1-10. DOI: 10.1259/bjr/38447238.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mayoral LP, Andrade GM, Mayoral EP, et al. Obesity subtypes, related biomarkers &amp; heterogeneity. Indian J Med Res. 2020;151(1):11-21. DOI: 10.4103/ijmr.IJMR_1768_17.</mixed-citation><mixed-citation xml:lang="en">Mayoral LP, Andrade GM, Mayoral EP, et al. Obesity subtypes, related biomarkers &amp; heterogeneity. Indian J Med Res. 2020;151(1):11-21. DOI: 10.4103/ijmr.IJMR_1768_17.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Caballero B. Humans against Obesity: Who Will Win? Adv Nutr. 2019;10(suppl_1):S4-S9. DOI: 10.1093/advances/nmy055.</mixed-citation><mixed-citation xml:lang="en">Caballero B. Humans against Obesity: Who Will Win? Adv Nutr. 2019;10(suppl_1):S4-S9. DOI: 10.1093/advances/nmy055.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Tirthani E, Said MS, Rehman A. Genetics and Obesity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.</mixed-citation><mixed-citation xml:lang="en">Tirthani E, Said MS, Rehman A. Genetics and Obesity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Mahmoud AM. An Overview of Epigenetics in Obesity: The Role of Lifestyle and Therapeutic Interventions. Int J Mol Sci. 2022;23(3):1341. DOI: 10.3390/ijms23031341.</mixed-citation><mixed-citation xml:lang="en">Mahmoud AM. An Overview of Epigenetics in Obesity: The Role of Lifestyle and Therapeutic Interventions. Int J Mol Sci. 2022;23(3):1341. DOI: 10.3390/ijms23031341.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Calcaterra V, Cena H, Rossi V, et al. Ultra-Processed Food, Reward System and Childhood Obesity. Children (Basel). 2023;10(5):804. DOI: 10.3390/children10050804.</mixed-citation><mixed-citation xml:lang="en">Calcaterra V, Cena H, Rossi V, et al. Ultra-Processed Food, Reward System and Childhood Obesity. Children (Basel). 2023;10(5):804. DOI: 10.3390/children10050804.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Olateju IV, Opaleye-Enakhimion T, Udeogu JE, et al. A systematic review on the effectiveness of diet and exercise in the management of obesity. Diabetes Metab Syndr. 2023;17(4):102759. DOI: 10.1016/j.dsx.2023.102759.</mixed-citation><mixed-citation xml:lang="en">Olateju IV, Opaleye-Enakhimion T, Udeogu JE, et al. A systematic review on the effectiveness of diet and exercise in the management of obesity. Diabetes Metab Syndr. 2023;17(4):102759. DOI: 10.1016/j.dsx.2023.102759.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Fitch AK, Bays HE. Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: an Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obes Pillars. 2022;1:100004. DOI: 10.1016/j.obpill.2021.100004.</mixed-citation><mixed-citation xml:lang="en">Fitch AK, Bays HE. Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: an Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obes Pillars. 2022;1:100004. DOI: 10.1016/j.obpill.2021.100004.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Bays H. Adiposopathy, "sick fat," Ockham’s razor, and resolution of the obesity paradox. Curr Atheroscler Rep. 2014;16(5):409. DOI: 10.1007/s11883-014-0409-1.</mixed-citation><mixed-citation xml:lang="en">Bays H. Adiposopathy, "sick fat," Ockham’s razor, and resolution of the obesity paradox. Curr Atheroscler Rep. 2014;16(5):409. DOI: 10.1007/s11883-014-0409-1.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Freshwater M, Christensen S, Oshman L, Bays HE. Behavior, motivational interviewing, eating disorders, and obesity management technologies: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obes Pillars. 2022;2:100014. DOI: 10.1016/j.obpill.2022.100014.</mixed-citation><mixed-citation xml:lang="en">Freshwater M, Christensen S, Oshman L, Bays HE. Behavior, motivational interviewing, eating disorders, and obesity management technologies: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obes Pillars. 2022;2:100014. DOI: 10.1016/j.obpill.2022.100014.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Thaler RH, Sunstein CR, Balz JP. Choice architecture. In: Shafir E (editor), The behavioral foundations of public policy. 2012. DOI: 10.2139/ssrn.1583509.</mixed-citation><mixed-citation xml:lang="en">Thaler RH, Sunstein CR, Balz JP. Choice architecture. In: Shafir E (editor), The behavioral foundations of public policy. 2012. DOI: 10.2139/ssrn.1583509.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Faith MS, Berkowitz RI, Stallings VA, et al. Eating in the absence of hunger: a genetic marker for childhood obesity in prepubertal boys? Obesity (Silver Spring). 2006;14(1):131-8. DOI: 10.1038/oby.2006.16.</mixed-citation><mixed-citation xml:lang="en">Faith MS, Berkowitz RI, Stallings VA, et al. Eating in the absence of hunger: a genetic marker for childhood obesity in prepubertal boys? Obesity (Silver Spring). 2006;14(1):131-8. DOI: 10.1038/oby.2006.16.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Елиашевич С. О., Нуньес Араухо Д. Д., Драпкина О. М. Пищевое поведение: нарушения и способы их оценки. Кардиоваскулярная терапия и профилактика. 2023;22(8):3663. DOI: 10.15829/1728-8800-2023-3663.</mixed-citation><mixed-citation xml:lang="en">Eliashevich SO, Nuňez Araujo DD, Drapkina OM. Eating behavior: disorders and how to assess them. Cardiovascular Therapy and Prevention. 2023;22(8):3663 (In Russ) DOI: 10.15829/1728-8800-2023-3663.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Ursell LK, Metcalf JL, Parfrey LW, Knight R. Defining the human microbiome. Nutr Rev. 2012;70 (Suppl 1):S38-S44. DOI: 10.1111/j.1753-4887.2012.00493.x.</mixed-citation><mixed-citation xml:lang="en">Ursell LK, Metcalf JL, Parfrey LW, Knight R. Defining the human microbiome. Nutr Rev. 2012;70 (Suppl 1):S38-S44. DOI: 10.1111/j.1753-4887.2012.00493.x.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Karczewski J, Zielinska A, Staszewski R, et al. Obesity and the Brain. Int J Mol Sci. 2022;23(11):6145. DOI: 10.3390/ijms23116145.</mixed-citation><mixed-citation xml:lang="en">Karczewski J, Zielinska A, Staszewski R, et al. Obesity and the Brain. Int J Mol Sci. 2022;23(11):6145. DOI: 10.3390/ijms23116145.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Shetye B, Hamilton FR, Bays HE. Bariatric surgery, gastrointestinal hormones, and the microbiome: an obesity medicine association (OMA) clinical practice statement (CPS) 2022. Obes Pillars. 2022;2:100015. DOI: 10.1016/j.obpill.2022.100015.</mixed-citation><mixed-citation xml:lang="en">Shetye B, Hamilton FR, Bays HE. Bariatric surgery, gastrointestinal hormones, and the microbiome: an obesity medicine association (OMA) clinical practice statement (CPS) 2022. Obes Pillars. 2022;2:100015. DOI: 10.1016/j.obpill.2022.100015.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Li D, Li Y, Yang S, et al. Diet-gut microbiota-epigenetics in metabolic diseases: From mechanisms to therapeutics. Biomed Pharmacother. 2022;153:113290. DOI: 10.1016/j.biopha.2022.113290.</mixed-citation><mixed-citation xml:lang="en">Li D, Li Y, Yang S, et al. Diet-gut microbiota-epigenetics in metabolic diseases: From mechanisms to therapeutics. Biomed Pharmacother. 2022;153:113290. DOI: 10.1016/j.biopha.2022.113290.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Vallianou N, Dalamaga M, Stratigou T, et al. Do Antibiotics Cause Obesity Through Long-term Alterations in the Gut Microbiome? A Review of Current Evidence. Curr Obes Rep. 2021;10(3):244-62. DOI: 10.1007/s13679-021-00438-w.</mixed-citation><mixed-citation xml:lang="en">Vallianou N, Dalamaga M, Stratigou T, et al. Do Antibiotics Cause Obesity Through Long-term Alterations in the Gut Microbiome? A Review of Current Evidence. Curr Obes Rep. 2021;10(3):244-62. DOI: 10.1007/s13679-021-00438-w.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Allegretti JR, Kassam Z, Mullish BH, et al. Effects of fecal microbiota transplantation with oral capsules in obese patients. Clin Gastroenterol Hepatol. 2020;18(4):855-63.e2. DOI: 10.1016/j.cgh.2019.07.006.</mixed-citation><mixed-citation xml:lang="en">Allegretti JR, Kassam Z, Mullish BH, et al. Effects of fecal microbiota transplantation with oral capsules in obese patients. Clin Gastroenterol Hepatol. 2020;18(4):855-63.e2. DOI: 10.1016/j.cgh.2019.07.006.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Sehgal K, Khanna S. Gut microbiota: a target for intervention in obesity. Expert Rev Gastroenterol Hepatol. 2021;15(10):1169-79. DOI: 10.1080/17474124.2021.1963232.</mixed-citation><mixed-citation xml:lang="en">Sehgal K, Khanna S. Gut microbiota: a target for intervention in obesity. Expert Rev Gastroenterol Hepatol. 2021;15(10):1169-79. DOI: 10.1080/17474124.2021.1963232.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Sahle Z, Engidaye G, Shenkute Gebreyes D. Fecal microbiota transplantation and next-generation therapies: A review on targeting dysbiosis in metabolic disorders and beyond. SAGE Open Med. 2024;12:20503121241257486. DOI: 10.1177/20503121241257486.</mixed-citation><mixed-citation xml:lang="en">Sahle Z, Engidaye G, Shenkute Gebreyes D. Fecal microbiota transplantation and next-generation therapies: A review on targeting dysbiosis in metabolic disorders and beyond. SAGE Open Med. 2024;12:20503121241257486. DOI: 10.1177/20503121241257486.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Koliada A, Syzenko, G, Moseiko V, et al. Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiol. 2017;17(1):120. DOI: 10.1186/s12866-017-1027-1.</mixed-citation><mixed-citation xml:lang="en">Koliada A, Syzenko, G, Moseiko V, et al. Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiol. 2017;17(1):120. DOI: 10.1186/s12866-017-1027-1.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Yan H, Qin Q, Chen J, et al. Gut Microbiome Alterations in Patients With Visceral Obesity Based on Quantitative Computed Tomography. Front Cell Infect Microbiol. 2022;11:823262. DOI: 10.3389/fcimb.2021.823262.</mixed-citation><mixed-citation xml:lang="en">Yan H, Qin Q, Chen J, et al. Gut Microbiome Alterations in Patients With Visceral Obesity Based on Quantitative Computed Tomography. Front Cell Infect Microbiol. 2022;11:823262. DOI: 10.3389/fcimb.2021.823262.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334(6052):105-8. DOI: 10.1126/science.1208344.</mixed-citation><mixed-citation xml:lang="en">Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334(6052):105-8. DOI: 10.1126/science.1208344.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA. 2010;107(33):14691-6. DOI: 10.1073/pnas.1005963107.</mixed-citation><mixed-citation xml:lang="en">De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA. 2010;107(33):14691-6. DOI: 10.1073/pnas.1005963107.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Kaiser T, Nalluri H, Zhu Z, Staley C. Donor Microbiota Composition and Housing Affect Recapitulation of Obese Phenotypes in a Human Microbiota-Associated Murine Model. Front Cell Infect Microbiol. 2021;11:614218. DOI: 10.3389/fcimb.2021.614218.</mixed-citation><mixed-citation xml:lang="en">Kaiser T, Nalluri H, Zhu Z, Staley C. Donor Microbiota Composition and Housing Affect Recapitulation of Obese Phenotypes in a Human Microbiota-Associated Murine Model. Front Cell Infect Microbiol. 2021;11:614218. DOI: 10.3389/fcimb.2021.614218.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Phelan SM, Burgess DJ, Yeazel MW, et al. Impact of weight bias and stigma on quality of care and outcomes for patients with obesity. Obes Rev. 2015;16(4):319-26. DOI: 10.1111/obr.12266.</mixed-citation><mixed-citation xml:lang="en">Phelan SM, Burgess DJ, Yeazel MW, et al. Impact of weight bias and stigma on quality of care and outcomes for patients with obesity. Obes Rev. 2015;16(4):319-26. DOI: 10.1111/obr.12266.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275. DOI: 10.3390/ijms21176275.</mixed-citation><mixed-citation xml:lang="en">Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275. DOI: 10.3390/ijms21176275.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Singh S, Shankar R, Singh GP. Prevalence and associated risk factors of hypertension: a cross-sectional study in urban Varanasi. Int J Hypertens. 2017;2017:5491838. DOI: 10.1155/2017/5491838.</mixed-citation><mixed-citation xml:lang="en">Singh S, Shankar R, Singh GP. Prevalence and associated risk factors of hypertension: a cross-sectional study in urban Varanasi. Int J Hypertens. 2017;2017:5491838. DOI: 10.1155/2017/5491838.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И. Е., Чихладзе Н. М., Блинова Н. В., др. Евразийские клинические рекомендации по диагностике и лечению вторичных (симптоматических) форм артериальной гипертонии (2022). Евразийский Кардиологический Журнал. 2023;(1):6-65. DOI: 10.38109/2225-1685-2023-1-6-65.</mixed-citation><mixed-citation xml:lang="en">Chazova IE, Chikhladze NM, Blinova NV, et al. Eurasian clinical guidelines for the diagnosis and treatment of secondary (symptomatic) forms of arterial hypertension (2022). Eurasian heart journal. 2023;(1):6-65 (In Russ.) DOI: 10.38109/2225-1685-2023-1-6-65.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
